Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanocortin receptor type 3 (MC3R) is a G protein-coupled receptor (GPCR) that plays a significant role in regulating energy homeostasis, appetite, growth, puberty timing, and circadian rhythms. It is one of five known melanocortin receptors. MC3R is expressed widely in the central nervous system (CNS) and in peripheral tissues. Upon ligand binding (Alpha-, beta-, gamma-melanocyte-stimulating hormones (MSH), Adrenocorticotropic hormone (ACTH)), MC3R activates G proteins that stimulate adenylate cyclase activity leading to increased cyclic AMP (cAMP) production. Dysfunction in MC3R can lead to significant effects on body weight regulation, growth abnormalities, altered pubertal timing, and disrupted circadian rhythms. Specific small molecule agonists targeting MC3R are being explored as potential novel therapeutics for inflammatory conditions.
G protein activation, adenylate cyclase stimulation, cAMP production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin Receptor Type 3 (MC3R).